CPRX - Catalyst Pharmaceuticals Inc. (CPRX) CEO Patrick McEnany on Q3 2020 Results - Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Alicia Grande - Chief Financial Officer Patrick McEnany - Chairman & Chief Executive Officer Steven Miller - Chief Operating Officer & Chief Scientific Officer Jeffrey Del Carmen - Chief Commercial Officer Conference Call Participants Joe Catanzaro - Piper Sandler Charles Duncan - Cantor Fitzgerald Scott Henry - Roth Capital Presentation Operator Greetings and welcome to Catalyst Pharmaceuticals, CPRX Third Quarter 2020 Results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host Alicia Grande, Chief Financial Officer. Alicia Grande Good morning everyone and welcome to today's conference call. Joining me on today's call are members of the Catalyst executive team including Patrick McEnany,
For further details see:
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q3 2020 Results - Earnings Call Transcript